First National Bank of Omaha Makes New $595,000 Investment in Corteva, Inc. $CTVA

First National Bank of Omaha purchased a new stake in Corteva, Inc. (NYSE:CTVA) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 7,097 shares of the company’s stock, valued at approximately $595,000.

Other large investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of Corteva during the 2nd quarter worth approximately $4,560,180,000. Harris Associates L P raised its position in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares during the period. Norges Bank purchased a new stake in Corteva in the fourth quarter valued at approximately $504,001,000. Royal Bank of Canada boosted its position in shares of Corteva by 202.1% during the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after buying an additional 4,989,371 shares during the period. Finally, Bank of New York Mellon Corp purchased a new position in shares of Corteva during the second quarter worth $392,447,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Up 0.8%

Corteva stock opened at $78.51 on Thursday. The firm has a market capitalization of $52.38 billion, a P/E ratio of 51.99, a P/E/G ratio of 2.39 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The stock’s fifty day simple moving average is $81.92 and its 200-day simple moving average is $80.15.

Corteva (NYSE:CTVA) last released its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the previous year, the firm posted $2.20 EPS. Corteva’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is currently 47.68%.

Analyst Ratings Changes

CTVA has been the subject of a number of research reports. JPMorgan Chase & Co. lifted their price objective on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Mizuho raised their target price on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a report on Tuesday, July 14th. Rothschild & Co Redburn lifted their target price on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Barclays boosted their price target on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Finally, BNP Paribas Exane increased their price target on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.